Because the genes to be assessed contain approximately 59 haplotypes, a Bonferroni corrected alpha was set at. 00085 (.05/59). Estimates of the number of patients needed to identify the effect sizes obtained for candidate haplotypes examined in our pilot data ranged from 171 to 1,295 (alpha = .00085, beta = .8). These estimates were believed to be conservative Inhibitors,research,lifescience,medical because #Axitinib order randurls[1|1|,|CHEM1|]# 1) the inclusion of non-genetic factors should reduce the unexplained variance

in the model and increase power to detect the influence of genetic factors, 2) analyses will utilize repeated-measures logistic regression, which will increase power, and 3) for some genes, only specific risk Inhibitors,research,lifescience,medical haplotypes will be assessed so the actual number of haplotypes will likely be less than 59. Based on these analyses, recruitment of 936 patients is planned, in order to achieve at least 795 patients completing follow-up time points (estimated follow-up rate of 85%). Data Analysis DNA is extracted (average PAXgene DNA yield 150 μg to 500 μg) and targeted Inhibitors,research,lifescience,medical genotyping of single nucleotide polymorphisms (SNPs) is performed using the Sequenom (Sequenom, Inc., San Diego, CA) platform.

When possible, a haplotype-based approach to genetic analyses is utilized, because previous studies suggest that a haplotype-based approach to genetic analyses is often most useful. This is because the overall functional state of a gene may not be easily deduced from information regarding Inhibitors,research,lifescience,medical a single SNP [22]. For example, haplotype-dependent secondary RNA structure can have a much greater influence on function than a functional SNP within this haplotype [22]. To construct haplotypes, both functional SNPs previously shown to affect gene function and also tag SNP markers within Inhibitors,research,lifescience,medical each gene locus (to capture haplotypic diversity) are genotyped. Two hapmap samples, for which the entire genome sequence is known,

and 2 repeat samples are included in each genotyping batch to assess genotypic accuracy and reliability. Haplotypes are then constructed for each of the genetic risk factors assessed using the Haploview software program. Polymorphisms of interest include genetic variations influencing catecholamine levels (monoamine oxidase A, monoamine oxidase B, norepinephrine those transporter, catechol-O-methyltransferase) and adrenoreceptor function (α1A, α1B, α1D, α2A, α2B, α2C, β1, β1). Quality control of genetic data includes assessment of call rates for each SNP, identification of samples with call rates < 90%, and test of Hardy-Weinberg equilibriums for each locus. Genetic data results are then merged with phenotypic data and analyzed using standard statistical methods. Primary and secondary analyses evaluate genotypic and phenotypic predictors of persistent pain and psychological sequelae.